Clinical trials
Active, not recruiting Liver Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2009 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of California, San Francisco | 2 |
| ABK Biomedical | 1 |
| Baylor College of Medicine | 1 |
| Boston Scientific Corporation | 1 |
| Genentech, Inc. | 1 |
| Inventiva Pharma | 1 |
| M.D. Anderson Cancer Center | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| Prime Medicine, Inc. | 1 |
| University of North Carolina, Chapel Hill | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Diseases | 14 |
| Carcinoma, Hepatocellular | 3 |
| Fibrosis | 3 |
| Liver Neoplasms | 3 |
| Alcoholism | 2 |
| Digestive System Diseases | 2 |
| Digestive System Neoplasms | 2 |
| Genetic Diseases, Inborn | 2 |
| Metabolic Diseases | 2 |
| Metabolism, Inborn Errors | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.